Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul;47(7):100086.
doi: 10.1016/j.mocell.2024.100086. Epub 2024 Jun 21.

Genome editing using CRISPR, CAST, and Fanzor systems

Affiliations
Review

Genome editing using CRISPR, CAST, and Fanzor systems

Beomjong Song et al. Mol Cells. 2024 Jul.

Abstract

Genetic engineering technologies are essential not only for basic science but also for generating animal models for therapeutic applications. The clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas) system, derived from adapted prokaryotic immune responses, has led to unprecedented advancements in the field of genome editing because of its ability to precisely target and edit genes in a guide RNA-dependent manner. The discovery of various types of CRISPR-Cas systems, such as CRISPR-associated transposons (CASTs), has resulted in the development of novel genome editing tools. Recently, research has expanded to systems associated with obligate mobile element guided activity (OMEGA) RNAs, including ancestral CRISPR-Cas and eukaryotic Fanzor systems, which are expected to complement the conventional CRISPR-Cas systems. In this review, we briefly introduce the features of various CRISPR-Cas systems and their application in diverse animal models.

Keywords: Clustered regularly interspaced short palindromic repeats-associated protein; Clustered regularly interspaced short palindromic repeats-associated transposons; Fanzor; Genome editing; IscB; TnpB.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
History of research on CRISPR-Cas and OMEGA systems. It has taken more than 2 decades to demonstrate genome editing using the CRISPR-Cas system. Over the next 10 years, there has been remarkable progress in genome editing technology together with the discovery of diverse CRISPR-Cas variants (Cho et al., 2013a, Ishino et al., 1987, Jansen et al., 2002).
Fig. 2
Fig. 2
Structures of nuclease domains of CRISPR-Cas and OMEGA systems. The type II system has RuvC and HNH nucleases, whereas the type V system has only RuvC nuclease. Type VI systems contain RNA nucleases, such as HEPN. The OMEGA systems have only RuvC nuclease similar to the type V. HEPN, higher eukaryotic and prokaryotic nucleotide-binding.
Fig. 3
Fig. 3
Phylogenetic tree of CRISPR-Cas and OMEGA systems. OMEGA systems are phylogenetically correlated with the CRISPR-Cas system.

Similar articles

Cited by

References

    1. Abudayyeh O.O., Gootenberg J.S., Konermann S., Joung J., Slaymaker I.M., Cox D.B., Shmakov S., Makarova K.S., Semenova E., Minakhin L., et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 2016;353 - PMC - PubMed
    1. Altae-Tran H., Kannan S., Demircioglu F.E., Oshiro R., Nety S.P., McKay L.J., Dlakić M., Inskeep W.P., Makarova K.S., Macrae R.K., et al. The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases. Science. 2021;374:57–65. - PMC - PubMed
    1. Amrani N., Gao X.D., Liu P., Edraki A., Mir A., Ibraheim R., Gupta A., Sasaki K.E., Wu T., Donohoue P.D., et al. NmeCas9 is an intrinsically high-fidelity genome-editing platform. Genome Biol. 2018;19:214. - PMC - PubMed
    1. Anzalone A.V., Randolph P.B., Davis J.R., Sousa A.A., Koblan L.W., Levy J.M., Chen P.J., Wilson C., Newby G.A., Raguram A., et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576:149–157. - PMC - PubMed
    1. Arizti-Sanz J., Freije C.A., Stanton A.C., Petros B.A., Boehm C.K., Siddiqui S., Shaw B.M., Adams G., Kosoko-Thoroddsen T.F., Kemball M.E., et al. Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2. Nat. Commun. 2020;11:5921. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources